Radiation-related heart disease: current knowledge and future prospects - PubMed (original) (raw)
Review
. 2010 Mar 1;76(3):656-65.
doi: 10.1016/j.ijrobp.2009.09.064.
David J Cutter, Marjan Boerma, Louis S Constine, Luis F Fajardo, Kazunori Kodama, Kiyohiko Mabuchi, Lawrence B Marks, Fred A Mettler, Lori J Pierce, Klaus R Trott, Edward T H Yeh, Roy E Shore
Affiliations
- PMID: 20159360
- PMCID: PMC3910096
- DOI: 10.1016/j.ijrobp.2009.09.064
Review
Radiation-related heart disease: current knowledge and future prospects
Sarah C Darby et al. Int J Radiat Oncol Biol Phys. 2010.
Abstract
The heart has traditionally been considered a radio-resistant organ that would be unaffected by cardiac doses below about 30 Gray. During the last few years, however, evidence that radiation-related heart disease can occur following lower doses has emerged from several sources. These include studies of breast cancer patients, who received mean cardiac doses of 3–17 Gray when given radiotherapy following surgery, and studies of survivors of the atomic bombings of Japan who received doses of up to 4 Gray.
At doses above 30 Gray, radiation-related heart disease may occur within a year or two of exposure and risk increases with higher radiotherapy dose, younger age at irradiation, and the presence of conventional risk factors. At lower doses the typical latent period is much longer and is often more than a decade. However, the nature and magnitude of the risk following lower doses is not well characterized, and it is not yet clear whether there is a threshold dose below which there is no risk.
The evidence regarding radiation-related heart disease comes from several different disciplines. The present review brings together information from pathology, radiobiology, cardiology, radiation oncology and epidemiology. It summarises current knowledge, identifies gaps in that knowledge, and outlines some potential strategies for filling them. Further knowledge about the nature and magnitude of radiation-related heart disease would have immediate application in radiation oncology. It would also provide a basis for radiation protection policies for use in diagnostic radiology and occupational exposure.
Conflict of interest statement
Conflict of Interest Notification
The authors have no actual or potential conflicts of interest in relation to this work.
Figures
Fig. 1
Perpendicular sections of human pericardium. The left panel illustrates the normal parietal pericardium with a thin, uniform fibrous layer that faces the heart (upper section) and an outer layer of adipose tissue (lower section). The right panel is a typical example of irradiated pericardium at 17 months after receiving 67 Gy. The adipose tissue has been replaced by dense fibrous tissue that actually extends well below the limits of this micrograph. Hematoxylin-eosin stain. (From Kajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Keynote lecture. 5th Nordic Conference on Radiation Oncology. Bergen. Norway. Acta Oncologica 2005;44:13–22. with permission.)
Fig. 2
Fatal diffuse myocardial fibrosis several years after irradiation for Hodgkin’s disease. Whereas normally there should be very little collagen among the dark red myocytes, this heart muscle is criss-crossed by multiple bands of blue collagen. Gomori trichrome stain.
Fig. 3
Left anterior descending coronary artery in a 16-year-old boy 1 year after receiving 40 Gy mantle radiotherapy for Hodgkin’s disease. Myointimal proliferation has considerably narrowed the lumen. Fatal cases like this in a patient who had no cardiac risk factors other than radiation illustrate that the morphology of arterial disease due to radiation is essentially no different from that of age-related atherosclerosis. Hematoxylin-eosin stain. (From Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Keynote lecture. 5th Nordic Conference on Radiation Oncology, Bergen. Norway. Acta Oncologica 2005;44:13–22; with permission.)
Fig. 4
An outline of how microvascular and macrovascular radiation-related cardiac injury could theoretically combine to cause myocardial ischemia after RT.
Fig. 5
Left-sided vs. right-sided breast cancer. Mortality ratios by radiotherapy status, cause, and years since diagnosis in 300,000 women with breast cancer and registered in the Surveillance Epidemiology and End Results (SEER) cancer registries, 1973 to 2001 (From Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective study of about 300,000 women in US SEER cancel registries. Lancet Oncol 2005;6:557–565: with permission.)
Fig. 6
Representative axial images pre-RT (left panel) and post-RT (right panel) cardiac SPECT scans. The deep borders of the tangential RT beams are shown as solid lines. A new perfusion defect in the anterior left ventricle after radiation is seen.
Similar articles
- [Clinico-morphological characteristics of the radiation changes in the heart in cancer patients].
Musabaeva LI, Kolycheva NI. Musabaeva LI, et al. Vopr Onkol. 1982;28(6):88-94. Vopr Onkol. 1982. PMID: 6806981 Review. Russian. No abstract available. - Radiation pericarditis and myocardial fibrosis.
Westerhof PW, van der Putte CJ. Westerhof PW, et al. Eur J Cardiol. 1976 Jun;4(2):213-8. Eur J Cardiol. 1976. PMID: 1278209 - [Cardiac complications of thoracic radiotherapy].
Di Mattéo J, Vacheron A, Heulin A, Meeus L, Di Mattéo G, Gilles R, Delage F, de Ratuld A. Di Mattéo J, et al. Arch Mal Coeur Vaiss. 1978 Apr;71(4):447-52. Arch Mal Coeur Vaiss. 1978. PMID: 96762 Review. French. - Radiation induced pericarditis in Hodgkin's disease.
Marks RD Jr, Agarwal SK, Constable WC. Marks RD Jr, et al. Acta Radiol Ther Phys Biol. 1973 Aug;12(4):305-12. doi: 10.3109/02841867309131095. Acta Radiol Ther Phys Biol. 1973. PMID: 4201473 No abstract available. - [Contribution to the subject "Chronic pericarditis in Hodgkin disease"].
Gyenes G. Gyenes G. Orv Hetil. 2003 Dec 7;144(49):2443-4; author reply 2444. Orv Hetil. 2003. PMID: 14725212 Hungarian. No abstract available.
Cited by
- Echocardiographic Functional Outcomes Following Regional Nodal Irradiation for Breast Cancer Using Volumetric Modulated Arc Therapy.
Yu AF, White C, Zhang Z, Liu JE, Gillespie EF, McCormick B, Khan AJ, Steingart RM, Powell SN, Cahlon O, Braunstein LZ. Yu AF, et al. Adv Radiat Oncol. 2024 Jul 25;9(10):101581. doi: 10.1016/j.adro.2024.101581. eCollection 2024 Oct. Adv Radiat Oncol. 2024. PMID: 39258142 Free PMC article. - Do Oncologists Recommend the "Pill" of Physical Activity in Their Practice? Answers from the Oncologist and Patients' Perspectives.
Martínez Aguirre-Betolaza A, Dobaran Amezua A, Yagin FH, Cacicedo J, Olasagasti-Ibargoien J, Castañeda-Babarro A. Martínez Aguirre-Betolaza A, et al. Cancers (Basel). 2024 Apr 28;16(9):1720. doi: 10.3390/cancers16091720. Cancers (Basel). 2024. PMID: 38730668 Free PMC article. - A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing.
Muraleedharan A, Barik SK, Das DK, Das Majumdar SK, Mahapatra BR, Barik BK, Ramasubbu MK, M NHK, U PD, Ahmed SS, Mukherjee P, Pattanaik A, Badajena A, Mishra M, Kanungo S, Dhar SS, Parida DK. Muraleedharan A, et al. J Egypt Natl Canc Inst. 2024 Apr 8;36(1):11. doi: 10.1186/s43046-024-00214-6. J Egypt Natl Canc Inst. 2024. PMID: 38584227 - Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future.
Fang W, Xie S, Deng W. Fang W, et al. Cell Biol Toxicol. 2024 Mar 21;40(1):17. doi: 10.1007/s10565-024-09853-w. Cell Biol Toxicol. 2024. PMID: 38509409 Free PMC article. Review. - The intersection of heart failure and cancer in women: a review.
Tyebally S, Sia CH, Chen D, Abiodun A, Dalakoti M, Chan PF, Koo CY, Tan LL. Tyebally S, et al. Front Cardiovasc Med. 2024 Feb 28;11:1276141. doi: 10.3389/fcvm.2024.1276141. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38481958 Free PMC article. Review.
References
- Fajardo LF, Berthrong M, Anderson RE. Radiation pathology. New York: Oxford University Press; 2001.
- Schultz-Hector S, Trott KR. Radiation-induced cardiovascular diseases: Is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys. 2007;67:10–18. - PubMed
- Fajardo LF, Stewart JR. Pathogenesis of radiation-induced myocardial fibrosis. Lab Invest. 1973;29:244–257. - PubMed
- Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Keynote lecture, 5th Nordic Conference on Radiation Oncology, Bergen, Norway. Acta Oncologica. 2005;44:13–22. - PubMed
- Veinot JP, Edward WD. Pathology of radiation-induced heart disease: A surgical and autopsy study of 27 cases. Hum Pathol. 1996;8:766–773. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- MC_U137686858/MRC_/Medical Research Council/United Kingdom
- R01 CA069579/CA/NCI NIH HHS/United States
- ZIA CP010134/ImNIH/Intramural NIH HHS/United States
- ZIA CP010134-18/ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources